// App-Quantinova.ai

T4110 2016 AHA : Edoxaban for the Prevention of Thromboembolism in Patients With Bioprosthetic Valves in ENGAGE AF-TIMI 48

Researchers

Presenter

  • Raffaele De Caterina

Principal Investigators

  • Jonathan Halperin

  • Giulia Renda

  • Christian Ruff

  • Marco Trevisan

  • Francesco Nordio

  • Michele Mercuri

  • Daiichi Sankyo

  • Elliot Antman

  • Robert Giugliano

Medical Centers

  • Inst of Cardiology and Ctr of Excellence on Aging, G. -Annunzio Univ, Chieti, Italy

  • Inc, Parsippany, NJ

  • TIMI Study Group, Boston, MA

  • Brigham & Women's Hospital, Boston, MA

  • Mount Sinai Medical Center, New York, NY

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Cardiac valvular dysplasia X-linked

  • Severe Aortic Stenosis

  • Mitral valve regurgitation

  • Arrhythmia

  • Venous thrombosis

  • Ischemic stroke

  • Aortic stenosis

  • Mitral stenosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

  • Warfarin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved